<?xml version="1.0" encoding="UTF-8"?>
<akn:akomaNtoso xmlns:akn="http://docs.oasis-open.org/legaldocml/ns/akn/3.0"><akn:act><akn:meta><akn:identification source="#cosilico"><akn:FRBRWork prescriptive="true" authoritative="true"><akn:FRBRuri value="/akn/us/usc/42/285c–5" /><akn:FRBRdate date="2025-12-31" name="retrieval" /><akn:FRBRauthor href="#us-congress" /><akn:FRBRcountry value="us" /></akn:FRBRWork><akn:FRBRExpression><akn:FRBRuri value="/akn/us/usc/42/285c–5/eng@2025" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /><akn:FRBRlanguage language="en" /></akn:FRBRExpression><akn:FRBRManifestation><akn:FRBRuri value="/akn/us/usc/42/285c–5/eng@2025/main.xml" /><akn:FRBRdate date="2025-12-31" /><akn:FRBRauthor href="#cosilico" /></akn:FRBRManifestation></akn:identification></akn:meta><akn:body><akn:section eId="sec_285c_5"><akn:num>285c–5</akn:num><akn:heading>Research and training centers; development or expansion</akn:heading><akn:content><akn:p>§ 285c–5. Research and training centers; development or expansion(a) Diabetes mellitus and related endocrine and metabolic diseases(1) Consistent with applicable recommendations of the National Commission on Diabetes, the Director of the Institute shall provide for the development or substantial expansion of centers for research and training in diabetes mellitus and related endocrine and metabolic diseases. Each center developed or expanded under this subsection shall—(A) utilize the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting such research and training qualifications as may be prescribed by the Secretary; and

(B) conduct—(i) research in the diagnosis and treatment of diabetes mellitus and related endocrine and metabolic diseases and the complications resulting from such diseases;

(ii) training programs for physicians and allied health personnel in current methods of diagnosis and treatment of such diseases and complications, and in research in diabetes; and

(iii) information programs for physicians and allied health personnel who provide primary care for patients with such diseases or complications.



(2) A center may use funds provided under paragraph (1) to provide stipends for nurses and allied health professionals enrolled in research training programs described in paragraph (1)(B)(ii).


(b) Digestive diseases and related functional, congenital, metabolic disorders, and normal development of digestive tractConsistent with applicable recommendations of the National Digestive Diseases Advisory Board, the Director shall provide for the development or substantial expansion of centers for research in digestive diseases and related functional, congenital, metabolic disorders, and normal development of the digestive tract. Each center developed or expanded under this subsection—(1) shall utilize the facilities of a single institution, or be formed from a consortium of cooperating institutions, meeting su</akn:p></akn:content><akn:subsection eId="subsec_285c_5_a"><akn:num>(a)</akn:num><akn:heading>Diabetes mellitus and related endocrine and metabolic diseases</akn:heading><akn:content><akn:p>(a) Diabetes mellitus and related endocrine and metabolic diseases</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285c_5_b"><akn:num>(b)</akn:num><akn:heading>Digestive diseases and related functional, congenital, metabolic disorders, and normal development of digestive tract</akn:heading><akn:content><akn:p>(b) Digestive diseases and related functional, congenital, metabolic disorders, and normal development of digestive tract Consistent with applicable recommendations of the National Digestive Diseases Advisory Board, the Director shall provide for the development or substantial expansion of centers for research in digestive diseases and related functional, congenital, metabolic disorders, and normal development of the digestive tract. Each center developed or expanded under this subsection—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285c_5_c"><akn:num>(c)</akn:num><akn:heading>Kidney and urologic diseases</akn:heading><akn:content><akn:p>(c) Kidney and urologic diseases The Director shall provide for the development or substantial expansion of centers for research in kidney and urologic diseases. Each center developed or expanded under this subsection—</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285c_5_d"><akn:num>(d)</akn:num><akn:heading>Nutritional disorders</akn:heading><akn:content><akn:p>(d) Nutritional disorders</akn:p></akn:content></akn:subsection><akn:subsection eId="subsec_285c_5_e"><akn:num>(e)</akn:num><akn:heading>Geographic distribution; period of support, additional periods</akn:heading><akn:content><akn:p>(e) Geographic distribution; period of support, additional periods Insofar as practicable, centers developed or expanded under this section should be geographically dispersed throughout the United States and in environments with proven research capabilities. Support of a center under this section may be for a period of not to exceed five years and such period may be extended by the Director of the Institute for additional periods of not more than five years each if the operations of such center have been reviewed by an appropriate technical and scientific peer review group established by the Director and if such group has recommended to the Director that such period should be extended.</akn:p></akn:content></akn:subsection></akn:section></akn:body></akn:act></akn:akomaNtoso>